|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ITGA4-UBE2E3 (FusionGDB2 ID:40257) |
Fusion Gene Summary for ITGA4-UBE2E3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ITGA4-UBE2E3 | Fusion gene ID: 40257 | Hgene | Tgene | Gene symbol | ITGA4 | UBE2E3 | Gene ID | 3676 | 10477 |
Gene name | integrin subunit alpha 4 | ubiquitin conjugating enzyme E2 E3 | |
Synonyms | CD49D|IA4 | UBCH9|UbcM2 | |
Cytomap | 2q31.3 | 2q31.3 | |
Type of gene | protein-coding | protein-coding | |
Description | integrin alpha-4269C wild typeCD49 antigen-like family member DVLA-4 subunit alphaalpha 4 subunit of VLA-4 receptorantigen CD49D, alpha-4 subunit of VLA-4 receptorintegrin alpha-IVvery late activation protein 4 receptor, alpha 4 subunit | ubiquitin-conjugating enzyme E2 E3E2 ubiquitin-conjugating enzyme E3ubiquitin carrier protein E3ubiquitin conjugating enzyme E2E 3ubiquitin-conjugating enzyme E2-23 kDaubiquitin-conjugating enzyme E2E 3 (UBC4/5 homolog, yeast)ubiquitin-conjugating e | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P13612 | . | |
Ensembl transtripts involved in fusion gene | ENST00000339307, ENST00000397033, ENST00000478440, | ENST00000392415, ENST00000410062, ENST00000602710, ENST00000602837, ENST00000602959, ENST00000602475, ENST00000602632, | |
Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 12 X 11 X 6=792 |
# samples | 6 | 13 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/792*10)=-2.60698880705116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ITGA4 [Title/Abstract] AND UBE2E3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ITGA4(182347378)-UBE2E3(181925392), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ITGA4 | GO:0007159 | leukocyte cell-cell adhesion | 1715889 |
Hgene | ITGA4 | GO:0090074 | negative regulation of protein homodimerization activity | 12869515 |
Tgene | UBE2E3 | GO:0070534 | protein K63-linked ubiquitination | 20061386 |
Tgene | UBE2E3 | GO:0070936 | protein K48-linked ubiquitination | 20061386 |
Tgene | UBE2E3 | GO:0070979 | protein K11-linked ubiquitination | 20061386 |
Fusion gene breakpoints across ITGA4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across UBE2E3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-X6-A8C3-01A | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
Top |
Fusion Gene ORF analysis for ITGA4-UBE2E3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000339307 | ENST00000392415 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3CDS | ENST00000339307 | ENST00000410062 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3CDS | ENST00000339307 | ENST00000602710 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3UTR | ENST00000339307 | ENST00000602837 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3UTR | ENST00000339307 | ENST00000602959 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-intron | ENST00000339307 | ENST00000602475 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-intron | ENST00000339307 | ENST00000602632 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
In-frame | ENST00000397033 | ENST00000392415 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
In-frame | ENST00000397033 | ENST00000410062 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
In-frame | ENST00000397033 | ENST00000602710 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
5CDS-3UTR | ENST00000397033 | ENST00000602837 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
5CDS-3UTR | ENST00000397033 | ENST00000602959 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
5CDS-intron | ENST00000397033 | ENST00000602475 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
5CDS-intron | ENST00000397033 | ENST00000602632 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3CDS | ENST00000478440 | ENST00000392415 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3CDS | ENST00000478440 | ENST00000410062 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3CDS | ENST00000478440 | ENST00000602710 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3UTR | ENST00000478440 | ENST00000602837 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-3UTR | ENST00000478440 | ENST00000602959 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-intron | ENST00000478440 | ENST00000602475 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
intron-intron | ENST00000478440 | ENST00000602632 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000397033 | ITGA4 | chr2 | 182347378 | + | ENST00000392415 | UBE2E3 | chr2 | 181925392 | + | 2252 | 1471 | 13 | 1716 | 567 |
ENST00000397033 | ITGA4 | chr2 | 182347378 | + | ENST00000410062 | UBE2E3 | chr2 | 181925392 | + | 2270 | 1471 | 13 | 1716 | 567 |
ENST00000397033 | ITGA4 | chr2 | 182347378 | + | ENST00000602710 | UBE2E3 | chr2 | 181925392 | + | 2270 | 1471 | 13 | 1716 | 567 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000397033 | ENST00000392415 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + | 0.000696846 | 0.9993031 |
ENST00000397033 | ENST00000410062 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + | 0.0006679 | 0.99933213 |
ENST00000397033 | ENST00000602710 | ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925392 | + | 0.0006679 | 0.99933213 |
Top |
Fusion Genomic Features for ITGA4-UBE2E3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925391 | + | 1.79E-05 | 0.9999821 |
ITGA4 | chr2 | 182347378 | + | UBE2E3 | chr2 | 181925391 | + | 1.79E-05 | 0.9999821 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ITGA4-UBE2E3 |
Go to FGviewer for the breakpoints of chr2:182347378-chr2:181925392 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ITGA4 | . |
FUNCTION: Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha-4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-4/beta-7 is also a receptor for MADCAM1. It recognizes the sequence L-D-T in MADCAM1. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyte cell lines. It may also participate in cytolytic T-cell interactions with target cells. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415). ITGA4:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). {ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:25398877}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 314_322 | 347.0 | 1033.0 | Calcium binding | Ontology_term=ECO:0000255 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 110_177 | 347.0 | 1033.0 | Repeat | FG-GAP 2 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 185_237 | 347.0 | 1033.0 | Repeat | FG-GAP 3 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 238_291 | 347.0 | 1033.0 | Repeat | FG-GAP 4 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 35_100 | 347.0 | 1033.0 | Repeat | FG-GAP 1 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 377_385 | 347.0 | 1033.0 | Calcium binding | Ontology_term=ECO:0000255 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 439_447 | 347.0 | 1033.0 | Calcium binding | Ontology_term=ECO:0000255 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 1003_1007 | 347.0 | 1033.0 | Motif | Note=GFFKR motif |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 606_616 | 347.0 | 1033.0 | Motif | Note=SG1 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 292_351 | 347.0 | 1033.0 | Repeat | FG-GAP 5 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 355_412 | 347.0 | 1033.0 | Repeat | FG-GAP 6 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 416_478 | 347.0 | 1033.0 | Repeat | FG-GAP 7 |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 1002_1032 | 347.0 | 1033.0 | Topological domain | Cytoplasmic |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 35_977 | 347.0 | 1033.0 | Topological domain | Extracellular |
Hgene | ITGA4 | chr2:182347378 | chr2:181925392 | ENST00000397033 | + | 9 | 28 | 978_1001 | 347.0 | 1033.0 | Transmembrane | Helical |
Tgene | UBE2E3 | chr2:182347378 | chr2:181925392 | ENST00000392415 | 3 | 6 | 61_207 | 126.0 | 208.0 | Domain | UBC core | |
Tgene | UBE2E3 | chr2:182347378 | chr2:181925392 | ENST00000410062 | 3 | 6 | 61_207 | 126.0 | 208.0 | Domain | UBC core | |
Tgene | UBE2E3 | chr2:182347378 | chr2:181925392 | ENST00000602710 | 3 | 6 | 61_207 | 126.0 | 208.0 | Domain | UBC core | |
Tgene | UBE2E3 | chr2:182347378 | chr2:181925392 | ENST00000602959 | 4 | 7 | 61_207 | 126.0 | 208.0 | Domain | UBC core |
Top |
Fusion Gene Sequence for ITGA4-UBE2E3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000397033_ENST00000392415_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(transcript)=2252nt_BP=1471nt GCCATCCCGCGCTCTGCGGGCTGGGAGGCCCGGGCCAGGACGCGAGTCCTGCGCAGCCGAGGTTCCCCAGCGCCCCCTGCAGCCGCGCGT AGGCAGAGACGGAGCCCGGCCCTGCGCCTCCGCACCACGCCCGGGACCCCACCCAGCGGCCCGTACCCGGAGAAGCAGCGCGAGCACCCG AAGCTCCCGGCTGGCGGCAGAAACCGGGAGTGGGGCCGGGCGAGTGCGCGGCATCCCAGGCCGGCCCGAACGCTCCGCCCGCGGTGGGCC GACTTCCCCTCCTCTTCCCTCTCTCCTTCCTTTAGCCCGCTGGCGCCGGACACGCTGCGCCTCATCTCTTGGGGCGTTCTTCCCCGTTGG CCAACCGTCGCATCCCGTGCAACTTTGGGGTAGTGGCCGTTTAGTGTTGAATGTTCCCCACCGAGAGCGCATGGCTTGGGAAGCGAGGCG CGAACCCGGCCCCCGAAGGGCCGCCGTCCGGGAGACGGTGATGCTGTTGCTGTGCCTGGGGGTCCCGACCGGCCGCCCCTACAACGTGGA CACTGAGAGCGCGCTGCTTTACCAGGGCCCCCACAACACGCTGTTCGGCTACTCGGTCGTGCTGCACAGCCACGGGGCGAACCGATGGCT CCTAGTGGGTGCGCCCACTGCCAACTGGCTCGCCAACGCTTCAGTGATCAATCCCGGGGCGATTTACAGATGCAGGATCGGAAAGAATCC CGGCCAGACGTGCGAACAGCTCCAGCTGGGTAGCCCTAATGGAGAACCTTGTGGAAAGACTTGTTTGGAAGAGAGAGACAATCAGTGGTT GGGGGTCACACTTTCCAGACAGCCAGGAGAAAATGGATCCATCGTGACTTGTGGGCATAGATGGAAAAATATATTTTACATAAAGAATGA AAATAAGCTCCCCACTGGTGGTTGCTATGGAGTGCCCCCTGATTTACGAACAGAACTGAGTAAAAGAATAGCTCCGTGTTATCAAGATTA TGTGAAAAAATTTGGAGAAAATTTTGCATCATGTCAAGCTGGAATATCCAGTTTTTACACAAAGGATTTAATTGTGATGGGGGCCCCAGG ATCATCTTACTGGACTGGCTCTCTTTTTGTCTACAATATAACTACAAATAAATACAAGGCTTTTTTAGACAAACAAAATCAAGTAAAATT TGGAAGTTATTTAGGATATTCAGTCGGAGCTGGTCATTTTCGGAGCCAGCATACTACCGAAGTAGTCGGAGGAGCTCCTCAACATGAGCA GATTGGTAAGGCATATATATTCAGCATTGATGAAAAAGAACTAAATATCTTACATGAAATGAAAGGTAAAAAGCTTGGATCGTACTTTGG AGCTTCTGTCTGTGCTGTGGACCTCAATGCAGATGGCTTCTCAGATCTGCTCGTGGGAGCACCCATGCAGAGCACCATCAGAGAGGAAGG AAGAGTGTTTGTGTACATCAACTCTGGCTCGGTTACTTTCCGCACCAGAATCTATCACTGCAACATCAACAGTCAGGGAGTCATCTGTCT GGACATCCTTAAAGACAACTGGAGTCCCGCTTTGACTATTTCAAAGGTTTTGCTGTCTATTTGTTCCCTTTTGACAGACTGCAACCCTGC GGATCCTCTGGTTGGAAGCATAGCCACTCAGTATTTGACCAACAGAGCAGAACACGACAGGATAGCCAGACAGTGGACCAAGAGATACGC AACATAATTCACATAATTTGTATGCAGTGTGAAGGAGCAGAAGGCATCTTCTCACTGTGCTGCAAATCTTTATAGCCTTTACAATACGGA CTTCTGTGTATATGTTATACTGATTCTACTCTGCTTTTATCCTTTGGAGCCTGGGAGACTCCCCAAAAAGGTAAATGCTATCAAGAGTAG AACTTTGTAGCTGTAGATTAGTTATGTTTAAAACGCCTACTTGCAAGTCTTGCTTCTTTGGGATATCAAAATGTATTTTGTGATGTACTA AGGATACTGGTCCTGAAGTCTACCAAATATTATAGTGCATTTTAGCCTAATTCATTATCTGTATGAAGTTATAAAAGTAGCTGTAGATGG CTAGGAATTATGTCATTTGTATTAAACCCAGATCTATTTCTGAGTATGTGGTTCATGCTGTTGTGAAAAATGTTTTACCTTTTACCTTTG TCAGTTTGTAATGAGAGGATTTCCTTTTACCCTTTGTAGCTCAGAGAGCACCTGATGTATCATCTCAAACACAATAAACATGCTCCTGAA >In-frame_ENST00000397033_ENST00000392415_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(amino acids)=567AA_start in transcript=13_stop in transcript=1716 MRAGRPGPGRESCAAEVPQRPLQPRVGRDGARPCASAPRPGPHPAARTRRSSASTRSSRLAAETGSGAGRVRGIPGRPERSARGGPTSPP LPSLLPLARWRRTRCASSLGAFFPVGQPSHPVQLWGSGRLVLNVPHRERMAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESA LLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTL SRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYW TGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVC AVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLV -------------------------------------------------------------- >In-frame_ENST00000397033_ENST00000410062_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(transcript)=2270nt_BP=1471nt GCCATCCCGCGCTCTGCGGGCTGGGAGGCCCGGGCCAGGACGCGAGTCCTGCGCAGCCGAGGTTCCCCAGCGCCCCCTGCAGCCGCGCGT AGGCAGAGACGGAGCCCGGCCCTGCGCCTCCGCACCACGCCCGGGACCCCACCCAGCGGCCCGTACCCGGAGAAGCAGCGCGAGCACCCG AAGCTCCCGGCTGGCGGCAGAAACCGGGAGTGGGGCCGGGCGAGTGCGCGGCATCCCAGGCCGGCCCGAACGCTCCGCCCGCGGTGGGCC GACTTCCCCTCCTCTTCCCTCTCTCCTTCCTTTAGCCCGCTGGCGCCGGACACGCTGCGCCTCATCTCTTGGGGCGTTCTTCCCCGTTGG CCAACCGTCGCATCCCGTGCAACTTTGGGGTAGTGGCCGTTTAGTGTTGAATGTTCCCCACCGAGAGCGCATGGCTTGGGAAGCGAGGCG CGAACCCGGCCCCCGAAGGGCCGCCGTCCGGGAGACGGTGATGCTGTTGCTGTGCCTGGGGGTCCCGACCGGCCGCCCCTACAACGTGGA CACTGAGAGCGCGCTGCTTTACCAGGGCCCCCACAACACGCTGTTCGGCTACTCGGTCGTGCTGCACAGCCACGGGGCGAACCGATGGCT CCTAGTGGGTGCGCCCACTGCCAACTGGCTCGCCAACGCTTCAGTGATCAATCCCGGGGCGATTTACAGATGCAGGATCGGAAAGAATCC CGGCCAGACGTGCGAACAGCTCCAGCTGGGTAGCCCTAATGGAGAACCTTGTGGAAAGACTTGTTTGGAAGAGAGAGACAATCAGTGGTT GGGGGTCACACTTTCCAGACAGCCAGGAGAAAATGGATCCATCGTGACTTGTGGGCATAGATGGAAAAATATATTTTACATAAAGAATGA AAATAAGCTCCCCACTGGTGGTTGCTATGGAGTGCCCCCTGATTTACGAACAGAACTGAGTAAAAGAATAGCTCCGTGTTATCAAGATTA TGTGAAAAAATTTGGAGAAAATTTTGCATCATGTCAAGCTGGAATATCCAGTTTTTACACAAAGGATTTAATTGTGATGGGGGCCCCAGG ATCATCTTACTGGACTGGCTCTCTTTTTGTCTACAATATAACTACAAATAAATACAAGGCTTTTTTAGACAAACAAAATCAAGTAAAATT TGGAAGTTATTTAGGATATTCAGTCGGAGCTGGTCATTTTCGGAGCCAGCATACTACCGAAGTAGTCGGAGGAGCTCCTCAACATGAGCA GATTGGTAAGGCATATATATTCAGCATTGATGAAAAAGAACTAAATATCTTACATGAAATGAAAGGTAAAAAGCTTGGATCGTACTTTGG AGCTTCTGTCTGTGCTGTGGACCTCAATGCAGATGGCTTCTCAGATCTGCTCGTGGGAGCACCCATGCAGAGCACCATCAGAGAGGAAGG AAGAGTGTTTGTGTACATCAACTCTGGCTCGGTTACTTTCCGCACCAGAATCTATCACTGCAACATCAACAGTCAGGGAGTCATCTGTCT GGACATCCTTAAAGACAACTGGAGTCCCGCTTTGACTATTTCAAAGGTTTTGCTGTCTATTTGTTCCCTTTTGACAGACTGCAACCCTGC GGATCCTCTGGTTGGAAGCATAGCCACTCAGTATTTGACCAACAGAGCAGAACACGACAGGATAGCCAGACAGTGGACCAAGAGATACGC AACATAATTCACATAATTTGTATGCAGTGTGAAGGAGCAGAAGGCATCTTCTCACTGTGCTGCAAATCTTTATAGCCTTTACAATACGGA CTTCTGTGTATATGTTATACTGATTCTACTCTGCTTTTATCCTTTGGAGCCTGGGAGACTCCCCAAAAAGGTAAATGCTATCAAGAGTAG AACTTTGTAGCTGTAGATTAGTTATGTTTAAAACGCCTACTTGCAAGTCTTGCTTCTTTGGGATATCAAAATGTATTTTGTGATGTACTA AGGATACTGGTCCTGAAGTCTACCAAATATTATAGTGCATTTTAGCCTAATTCATTATCTGTATGAAGTTATAAAAGTAGCTGTAGATGG CTAGGAATTATGTCATTTGTATTAAACCCAGATCTATTTCTGAGTATGTGGTTCATGCTGTTGTGAAAAATGTTTTACCTTTTACCTTTG TCAGTTTGTAATGAGAGGATTTCCTTTTACCCTTTGTAGCTCAGAGAGCACCTGATGTATCATCTCAAACACAATAAACATGCTCCTGAA >In-frame_ENST00000397033_ENST00000410062_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(amino acids)=567AA_start in transcript=13_stop in transcript=1716 MRAGRPGPGRESCAAEVPQRPLQPRVGRDGARPCASAPRPGPHPAARTRRSSASTRSSRLAAETGSGAGRVRGIPGRPERSARGGPTSPP LPSLLPLARWRRTRCASSLGAFFPVGQPSHPVQLWGSGRLVLNVPHRERMAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESA LLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTL SRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYW TGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVC AVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLV -------------------------------------------------------------- >In-frame_ENST00000397033_ENST00000602710_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(transcript)=2270nt_BP=1471nt GCCATCCCGCGCTCTGCGGGCTGGGAGGCCCGGGCCAGGACGCGAGTCCTGCGCAGCCGAGGTTCCCCAGCGCCCCCTGCAGCCGCGCGT AGGCAGAGACGGAGCCCGGCCCTGCGCCTCCGCACCACGCCCGGGACCCCACCCAGCGGCCCGTACCCGGAGAAGCAGCGCGAGCACCCG AAGCTCCCGGCTGGCGGCAGAAACCGGGAGTGGGGCCGGGCGAGTGCGCGGCATCCCAGGCCGGCCCGAACGCTCCGCCCGCGGTGGGCC GACTTCCCCTCCTCTTCCCTCTCTCCTTCCTTTAGCCCGCTGGCGCCGGACACGCTGCGCCTCATCTCTTGGGGCGTTCTTCCCCGTTGG CCAACCGTCGCATCCCGTGCAACTTTGGGGTAGTGGCCGTTTAGTGTTGAATGTTCCCCACCGAGAGCGCATGGCTTGGGAAGCGAGGCG CGAACCCGGCCCCCGAAGGGCCGCCGTCCGGGAGACGGTGATGCTGTTGCTGTGCCTGGGGGTCCCGACCGGCCGCCCCTACAACGTGGA CACTGAGAGCGCGCTGCTTTACCAGGGCCCCCACAACACGCTGTTCGGCTACTCGGTCGTGCTGCACAGCCACGGGGCGAACCGATGGCT CCTAGTGGGTGCGCCCACTGCCAACTGGCTCGCCAACGCTTCAGTGATCAATCCCGGGGCGATTTACAGATGCAGGATCGGAAAGAATCC CGGCCAGACGTGCGAACAGCTCCAGCTGGGTAGCCCTAATGGAGAACCTTGTGGAAAGACTTGTTTGGAAGAGAGAGACAATCAGTGGTT GGGGGTCACACTTTCCAGACAGCCAGGAGAAAATGGATCCATCGTGACTTGTGGGCATAGATGGAAAAATATATTTTACATAAAGAATGA AAATAAGCTCCCCACTGGTGGTTGCTATGGAGTGCCCCCTGATTTACGAACAGAACTGAGTAAAAGAATAGCTCCGTGTTATCAAGATTA TGTGAAAAAATTTGGAGAAAATTTTGCATCATGTCAAGCTGGAATATCCAGTTTTTACACAAAGGATTTAATTGTGATGGGGGCCCCAGG ATCATCTTACTGGACTGGCTCTCTTTTTGTCTACAATATAACTACAAATAAATACAAGGCTTTTTTAGACAAACAAAATCAAGTAAAATT TGGAAGTTATTTAGGATATTCAGTCGGAGCTGGTCATTTTCGGAGCCAGCATACTACCGAAGTAGTCGGAGGAGCTCCTCAACATGAGCA GATTGGTAAGGCATATATATTCAGCATTGATGAAAAAGAACTAAATATCTTACATGAAATGAAAGGTAAAAAGCTTGGATCGTACTTTGG AGCTTCTGTCTGTGCTGTGGACCTCAATGCAGATGGCTTCTCAGATCTGCTCGTGGGAGCACCCATGCAGAGCACCATCAGAGAGGAAGG AAGAGTGTTTGTGTACATCAACTCTGGCTCGGTTACTTTCCGCACCAGAATCTATCACTGCAACATCAACAGTCAGGGAGTCATCTGTCT GGACATCCTTAAAGACAACTGGAGTCCCGCTTTGACTATTTCAAAGGTTTTGCTGTCTATTTGTTCCCTTTTGACAGACTGCAACCCTGC GGATCCTCTGGTTGGAAGCATAGCCACTCAGTATTTGACCAACAGAGCAGAACACGACAGGATAGCCAGACAGTGGACCAAGAGATACGC AACATAATTCACATAATTTGTATGCAGTGTGAAGGAGCAGAAGGCATCTTCTCACTGTGCTGCAAATCTTTATAGCCTTTACAATACGGA CTTCTGTGTATATGTTATACTGATTCTACTCTGCTTTTATCCTTTGGAGCCTGGGAGACTCCCCAAAAAGGTAAATGCTATCAAGAGTAG AACTTTGTAGCTGTAGATTAGTTATGTTTAAAACGCCTACTTGCAAGTCTTGCTTCTTTGGGATATCAAAATGTATTTTGTGATGTACTA AGGATACTGGTCCTGAAGTCTACCAAATATTATAGTGCATTTTAGCCTAATTCATTATCTGTATGAAGTTATAAAAGTAGCTGTAGATGG CTAGGAATTATGTCATTTGTATTAAACCCAGATCTATTTCTGAGTATGTGGTTCATGCTGTTGTGAAAAATGTTTTACCTTTTACCTTTG TCAGTTTGTAATGAGAGGATTTCCTTTTACCCTTTGTAGCTCAGAGAGCACCTGATGTATCATCTCAAACACAATAAACATGCTCCTGAA >In-frame_ENST00000397033_ENST00000602710_TCGA-X6-A8C3-01A_ITGA4_chr2_182347378_+_UBE2E3_chr2_181925392_length(amino acids)=567AA_start in transcript=13_stop in transcript=1716 MRAGRPGPGRESCAAEVPQRPLQPRVGRDGARPCASAPRPGPHPAARTRRSSASTRSSRLAAETGSGAGRVRGIPGRPERSARGGPTSPP LPSLLPLARWRRTRCASSLGAFFPVGQPSHPVQLWGSGRLVLNVPHRERMAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESA LLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTL SRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYW TGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVC AVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ITGA4-UBE2E3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ITGA4-UBE2E3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | ITGA4 | P13612 | DB06822 | Tinzaparin | Inhibitor | Small molecule | Approved |
Hgene | ITGA4 | P13612 | DB06822 | Tinzaparin | Inhibitor | Small molecule | Approved |
Hgene | ITGA4 | P13612 | DB09033 | Vedolizumab | Antibody | Biotech | Approved |
Hgene | ITGA4 | P13612 | DB09033 | Vedolizumab | Antibody | Biotech | Approved |
Hgene | ITGA4 | P13612 | DB00108 | Natalizumab | Antibody | Biotech | Approved|Investigational |
Hgene | ITGA4 | P13612 | DB00108 | Natalizumab | Antibody | Biotech | Approved|Investigational |
Top |
Related Diseases for ITGA4-UBE2E3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ITGA4 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | ITGA4 | C0017639 | Gliosis | 1 | CTD_human |
Hgene | ITGA4 | C0021390 | Inflammatory Bowel Diseases | 1 | CTD_human |
Hgene | ITGA4 | C0023434 | Chronic Lymphocytic Leukemia | 1 | CTD_human |
Hgene | ITGA4 | C3887640 | Astrocytosis | 1 | CTD_human |